栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/12/11 | 1,748 | 1,748 | 1,714 | 1,725 | -3 | -0.2% | 135,500 |
| 2023/12/08 | 1,764 | 1,764 | 1,714 | 1,728 | -23 | -1.3% | 175,600 |
| 2023/12/07 | 1,749 | 1,768 | 1,743 | 1,751 | -13 | -0.7% | 119,600 |
| 2023/12/06 | 1,718 | 1,764 | 1,713 | 1,764 | +73 | +4.3% | 251,000 |
| 2023/12/05 | 1,694 | 1,704 | 1,683 | 1,691 | -10 | -0.6% | 117,800 |
| 2023/12/04 | 1,675 | 1,704 | 1,661 | 1,701 | +6 | +0.4% | 147,000 |
| 2023/12/01 | 1,680 | 1,714 | 1,680 | 1,695 | +48 | +2.9% | 283,600 |
| 2023/11/30 | 1,640 | 1,650 | 1,632 | 1,647 | -8 | -0.5% | 127,900 |
| 2023/11/29 | 1,638 | 1,664 | 1,638 | 1,655 | +11 | +0.7% | 131,500 |
| 2023/11/28 | 1,669 | 1,669 | 1,612 | 1,644 | -27 | -1.6% | 259,000 |
| 2023/11/27 | 1,665 | 1,696 | 1,665 | 1,671 | +6 | +0.4% | 195,900 |
| 2023/11/24 | 1,652 | 1,673 | 1,643 | 1,665 | +27 | +1.6% | 238,900 |
| 2023/11/22 | 1,623 | 1,650 | 1,618 | 1,638 | +28 | +1.7% | 297,800 |
| 2023/11/21 | 1,573 | 1,613 | 1,569 | 1,610 | +26 | +1.6% | 304,400 |
| 2023/11/20 | 1,559 | 1,591 | 1,556 | 1,584 | +29 | +1.9% | 275,100 |
| 2023/11/17 | 1,526 | 1,556 | 1,526 | 1,555 | +26 | +1.7% | 117,900 |
| 2023/11/16 | 1,560 | 1,564 | 1,528 | 1,529 | -26 | -1.7% | 118,500 |
| 2023/11/15 | 1,556 | 1,573 | 1,550 | 1,555 | ±0 | ±0% | 169,700 |
| 2023/11/14 | 1,558 | 1,573 | 1,533 | 1,555 | +45 | +3% | 190,500 |
| 2023/11/13 | 1,525 | 1,542 | 1,510 | 1,510 | -25 | -1.6% | 87,600 |
| 2023/11/10 | 1,536 | 1,545 | 1,522 | 1,535 | -16 | -1% | 186,100 |
| 2023/11/09 | 1,540 | 1,558 | 1,540 | 1,551 | +13 | +0.8% | 187,000 |
| 2023/11/08 | 1,528 | 1,539 | 1,516 | 1,538 | +9 | +0.6% | 368,500 |
| 2023/11/07 | 1,506 | 1,530 | 1,506 | 1,529 | +28 | +1.9% | 288,100 |
| 2023/11/06 | 1,521 | 1,525 | 1,497 | 1,501 | -11 | -0.7% | 265,200 |
| 2023/11/02 | 1,500 | 1,517 | 1,484 | 1,512 | +9 | +0.6% | 236,900 |
| 2023/11/01 | 1,505 | 1,516 | 1,492 | 1,503 | +18 | +1.2% | 336,700 |
| 2023/10/31 | 1,436 | 1,491 | 1,423 | 1,485 | +40 | +2.8% | 419,400 |
| 2023/10/30 | 1,427 | 1,452 | 1,415 | 1,445 | -5 | -0.3% | 1,318,700 |
| 2023/10/27 | 1,479 | 1,509 | 1,426 | 1,450 | +31 | +2.2% | 624,600 |
| 2023/10/26 | 1,442 | 1,444 | 1,413 | 1,419 | -22 | -1.5% | 300,400 |
| 2023/10/25 | 1,464 | 1,468 | 1,437 | 1,441 | -12 | -0.8% | 308,800 |
| 2023/10/24 | 1,430 | 1,457 | 1,416 | 1,453 | +9 | +0.6% | 311,600 |
| 2023/10/23 | 1,464 | 1,469 | 1,443 | 1,444 | -19 | -1.3% | 222,000 |
| 2023/10/20 | 1,440 | 1,465 | 1,437 | 1,463 | +28 | +2% | 209,900 |
| 2023/10/19 | 1,415 | 1,442 | 1,415 | 1,435 | +14 | +1% | 122,900 |
| 2023/10/18 | 1,439 | 1,444 | 1,418 | 1,421 | -3 | -0.2% | 104,100 |
| 2023/10/17 | 1,439 | 1,451 | 1,416 | 1,424 | -11 | -0.8% | 142,500 |
| 2023/10/16 | 1,432 | 1,446 | 1,428 | 1,435 | +3 | +0.2% | 164,600 |
| 2023/10/13 | 1,444 | 1,444 | 1,428 | 1,432 | -5 | -0.3% | 191,900 |
| 2023/10/12 | 1,425 | 1,438 | 1,418 | 1,437 | +2 | +0.1% | 174,900 |
| 2023/10/11 | 1,406 | 1,436 | 1,405 | 1,435 | +17 | +1.2% | 201,200 |
| 2023/10/10 | 1,402 | 1,420 | 1,399 | 1,418 | +24 | +1.7% | 234,100 |
| 2023/10/06 | 1,376 | 1,396 | 1,376 | 1,394 | +18 | +1.3% | 186,000 |
| 2023/10/05 | 1,349 | 1,379 | 1,348 | 1,376 | +36 | +2.7% | 230,400 |
| 2023/10/04 | 1,336 | 1,356 | 1,334 | 1,340 | +1 | +0.1% | 214,300 |
| 2023/10/03 | 1,360 | 1,367 | 1,337 | 1,339 | -26 | -1.9% | 245,300 |
| 2023/10/02 | 1,378 | 1,389 | 1,362 | 1,365 | -1 | -0.1% | 195,500 |
| 2023/09/29 | 1,369 | 1,374 | 1,358 | 1,366 | -3 | -0.2% | 148,200 |
| 2023/09/28 | 1,373 | 1,377 | 1,362 | 1,369 | -29 | -2.1% | 150,000 |
101～
150
件表示中 / 6707件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 207,300円 | +7.6% | +57.5% | 2.56% | 16.01倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割弱。尿検査（ウロ）、遺伝子検査も育成 |
| ゼリア新薬 | 203,900円 | +9.6% | +17.5% | 2.26% | 11.52倍 | 1.13倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ＪＣＲファーマ | 64,800円 | -3.7% | -36.7% | 3.09% | 21.85倍 | 1.46倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| あすかＨＤ | 247,600円 | +0.3% | +2.7% | 2.02% | 14.03倍 | 1.13倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| 生化学 | 73,700円 | +7.9% | -26.7% | 3.53% | 15.47倍 | 0.56倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
市場注目の銘柄
チャート関連のコラム
